92 related articles for article (PubMed ID: 10694922)
1. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online.
Klaus DJ; Gallione CJ; Anthony K; Yeh EY; Yu J; Lux A; Johnson DW; Marchuk DA
Hum Mutat; 1998; 12(2):137. PubMed ID: 10694922
[TBL] [Abstract][Full Text] [Related]
2. Disease-associated mutations in conserved residues of ALK-1 kinase domain.
Abdalla SA; Cymerman U; Johnson RM; Deber CM; Letarte M
Eur J Hum Genet; 2003 Apr; 11(4):279-87. PubMed ID: 12700602
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.
Johnson DW; Berg JN; Baldwin MA; Gallione CJ; Marondel I; Yoon SJ; Stenzel TT; Speer M; Pericak-Vance MA; Diamond A; Guttmacher AE; Jackson CE; Attisano L; Kucherlapati R; Porteous ME; Marchuk DA
Nat Genet; 1996 Jun; 13(2):189-95. PubMed ID: 8640225
[TBL] [Abstract][Full Text] [Related]
5. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
[TBL] [Abstract][Full Text] [Related]
6. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.
Ota T; Fujii M; Sugizaki T; Ishii M; Miyazawa K; Aburatani H; Miyazono K
J Cell Physiol; 2002 Dec; 193(3):299-318. PubMed ID: 12384983
[TBL] [Abstract][Full Text] [Related]
7. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.
Berg JN; Gallione CJ; Stenzel TT; Johnson DW; Allen WP; Schwartz CE; Jackson CE; Porteous ME; Marchuk DA
Am J Hum Genet; 1997 Jul; 61(1):60-7. PubMed ID: 9245985
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
[TBL] [Abstract][Full Text] [Related]
9. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
10. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.
Azuma H
J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486
[TBL] [Abstract][Full Text] [Related]
11. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.
ten Dijke P; Ichijo H; Franzén P; Schulz P; Saras J; Toyoshima H; Heldin CH; Miyazono K
Oncogene; 1993 Oct; 8(10):2879-87. PubMed ID: 8397373
[TBL] [Abstract][Full Text] [Related]
12. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemorrhagic telangiectasia.
Nguyen NQ
Dermatol Online J; 2005 Dec; 11(4):19. PubMed ID: 16403391
[TBL] [Abstract][Full Text] [Related]
14. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
15. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management.
Stuhrmann M; El-Harith el-HA
Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283
[TBL] [Abstract][Full Text] [Related]
16. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
Lux A; Attisano L; Marchuk DA
J Biol Chem; 1999 Apr; 274(15):9984-92. PubMed ID: 10187774
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
Fujiwara M; Yagi H; Matsuoka R; Saji T
Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation.
Lin WD; Wu JY; Hsu HB; Tsai FJ; Lee CC; Tsai CH
J Formos Med Assoc; 2001 Dec; 100(12):817-9. PubMed ID: 11802521
[TBL] [Abstract][Full Text] [Related]
20. Arteriovenous malformations in mice lacking activin receptor-like kinase-1.
Urness LD; Sorensen LK; Li DY
Nat Genet; 2000 Nov; 26(3):328-31. PubMed ID: 11062473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
